N-[(2s)-3-(3-Tert-Butyl-1,2,4-Oxadiazol-5-Yl)-1-({(2s)-1-[(4-Methylbenzyl)amino]-1-Oxo-4-Phenylbutan-2-Yl}amino)-1-Oxopropan-2-Yl]-5-Methyl-1,2-Oxazole-3-Carboxamide

InChIKey	`OHMJOYZRJHYMAE-DQEYMECFSA-N`
Compound Name	N-[(2s)-3-(3-Tert-Butyl-1,2,4-Oxadiazol-5-Yl)-1-({(2s)-1-[(4-Methylbenzyl)amino]-1-Oxo-4-Phenylbutan-2-Yl}amino)-1-Oxopropan-2-Yl]-5-Methyl-1,2-Oxazole-3-Carboxamide
Canonical SMILES	`Cc1ccc(CNC(=O)[C@H](CCc2ccccc2)NC(=O)[C@H](Cc2nc(C(C)(C)C)no2)NC(=O)c2cc(C)on2)cc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	6.29
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P28074	PSMB5	Homo sapiens	Human	PF00227	7.0	IC50	ChEMBL
P19838	NFKB1	Homo sapiens	Human	PF12796 PF00531 PF16179 PF00554	6.0	IC50	ChEMBL
Q00653	NFKB2	Homo sapiens	Human	PF00023 PF12796 PF00531 PF16179 PF00554	6.0	IC50	ChEMBL
Q04206	RELA	Homo sapiens	Human	PF16179 PF00554	6.0	IC50	ChEMBL